A carregar...
Minimal residual disease in acute myelogenous leukemia
Treatment of acute myelogenous leukemia (AML) over the past four decades remains mostly unchanged and the prognosis for the majority of patients remains poor. Most of the significant advances that have been observed are in defining cytogenetic abnormalities, as well as the genetic and epigenetic pro...
Na minha lista:
| Publicado no: | Int J Lab Hematol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652069/ https://ncbi.nlm.nih.gov/pubmed/28447422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijlh.12670 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|